Augmenting clinical trials in asthma through digital technology, decentralised designs, and person-centric endpoints: opportunities and challenges.
- DOI
- 10.1016/s2213-2600(24)00327-8
- Published
- 2025 Feb
- Container
- The Lancet. Respiratory medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s2213-2600-24-00327-8,
title = {Augmenting clinical trials in asthma through digital technology, decentralised designs, and person-centric endpoints: opportunities and challenges.},
author = {van Boven JFM and Costello RW and Roes KCB and Brusselle GG and Hansen K and Krishnan JA and Brightling CE and Roche N and Siddiqui S and Kirenga BJ and Pinnock H and Chan AHY},
year = {2025},
journal = {The Lancet. Respiratory medicine},
doi = {10.1016/s2213-2600(24)00327-8},
url = {https://doi.org/10.1016/s2213-2600(24)00327-8}
}RIS
TY - JOUR TI - Augmenting clinical trials in asthma through digital technology, decentralised designs, and person-centric endpoints: opportunities and challenges. AU - van Boven JFM AU - Costello RW AU - Roes KCB AU - Brusselle GG AU - Hansen K AU - Krishnan JA AU - Brightling CE AU - Roche N AU - Siddiqui S AU - Kirenga BJ AU - Pinnock H AU - Chan AHY PY - 2025 JO - The Lancet. Respiratory medicine DO - 10.1016/s2213-2600(24)00327-8 UR - https://doi.org/10.1016/s2213-2600(24)00327-8 ER -
APA
JFM, V. B., RW, C., KCB, R., GG, B., K, H., JA, K., CE, B., N, R., S, S., BJ, K., H, P., & AHY, C. (2025). Augmenting clinical trials in asthma through digital technology, decentralised designs, and person-centric endpoints: opportunities and challenges.. The Lancet. Respiratory medicine. https://doi.org/10.1016/s2213-2600(24)00327-8
Source records
- pubmed · retrieved 2026-09-27T11:28:08.535Z